MarleenKokLab
@lab_kok
medical oncologist, breast cancer immunotherapy investigator, mother, PI and associate prof at NKI, happy in Amsterdam
ID: 1269159592237453312
06-06-2020 06:50:16
684 Tweet
1,1K Followers
472 Following
Although treatm for TNBC has improved a lot, we still have 2 issues: overtreatm for many (TIL high) pts and no good treatm for substantial group (RCB3 and beyond). This review of my two fabulous PhD stud @LVoorwerk The Netherlands Cancer Institute provides concepts in this area doi.org/10.1158/1078-0…
